| Literature DB >> 33786113 |
Guiying Zhu1, Fenglin Hu1, Changmiao Wang1.
Abstract
Endoscopic retrograde cholangiopancreatography (ERCP) is the main diagnosis and treatment for biliary and pancreatic diseases; however, ERCP requires a high level of technical skill and experience, and there is always a risk of complications. ERCP-related duodenal perforation is one of the most serious complications of ERCP, and although the incidence rate is relatively low, the mortality rate is high. Recently, the introduction of new classification methods and the development of endoscopic technology and equipment have made endoscopic therapy a new trend. This may change the management strategy of perforation. Therefore, we reviewed the latest developments in endoscopic management, surgical management, and conservative internal medicine management. In addition to introducing many new endoscope treatment methods, we also discussed the timing of interventions, the progress of endoscope and surgical indications, and corresponding prevention strategies. We aim to retrospectively analyse these treatment modalities to propose appropriate solutions to improve dynamic clinical therapy. Copyright:Entities:
Keywords: duodenal perforation; endoscopic retrograde cholangiopancreatography; management; prevention strategy
Year: 2020 PMID: 33786113 PMCID: PMC7991950 DOI: 10.5114/wiitm.2020.101025
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
List of major studies
| Time of article published | Number of patients having ERCP | Number of patients with ERCP perforation (%) | Number of female perforation (%) | Average age [years] | Mortality (%) | Surgery ratio (%) | Surgery mortality rate (%) |
|---|---|---|---|---|---|---|---|
| 2020 [ | 25300 | 380 (1.5) | 16 (4.2) | 50 (13.2) | 16 (32) | ||
| 2019 [ | 19468 | 58 (0.29) | 36 (62) | 68.5 | 1 (1.7) | 2 (3.4) | 1 (50) |
| 2019 [ | 342 | 12 (3.5) | 7 (58) | 75.7 | |||
| 2018 [ | 4196 | 28 (0.67) | 14 (50) | 71.3 | 1 (3.57) | 6 (21.4) | 1 (16.7) |
| 2018 [ | 4513 | 36 (0.79) | 25 (69) | 72.02 | 4 (11.1) | 28 (78) | 2 (7.1) |
| 2018 [ | 7249 | 35 (0.48) | 26 (74) | 59 | 1 (2.86) | 2 (5.7) | 0 |
| 2018 [ | 3492 | 16 (0.4) | 12 (60) | 46 | 1 (5) | 5 (25) | 1 (20) |
| 2017 [ | 6934 | 37 (0.53) | 25 (67) | 70 | 4 (10.8) | 8 (22) | 1 (12.5) |
| 2017 [ | 2423 | 21 (0.9) | 11 (52) | 69.7 | 1 (4.8) | 4 (19) | 1 (25) |
| 2016 [ | 9383 | 29 (0.33) | 18 (62) | 70.5 | 10 (34.4) | 15 (51.7) | 7 (46.6) |
| 2016 [ | 3331 | 79 (2.37) | 71 (90) | 61 | |||
| 2015 [ | 4600 | 23(0.5) | 66.7 | 1 (4.3) | 11 (47.8) | 0 | |
| 2015 [ | 1923 | 15(0.78) | 12 (80) | 68.5 | 3 (20) | 8 (53) | 2 (25) |
| In total | 93154 | 769(0.8) | 257 (70.2) | 66.196 | 43 (6.3%) | 139 (20.5) | 32 (23) |
List of risk factors of iatrogenic duodenal perforations during endoscopic retrograde cholangiopancreatography
| Anatomy and disease-related risk factors | Operation-related risk factors |
|---|---|
| Suspicious Oddi sphincter dysfunction | Difficult intubation |
| Billroth II reconstruction | Intramucosal injection of contrast agent, |
| Duodenal diverticulum | Sphincterotomy and nipple pre-incision |
| Papillary stenosis | Biliary stricture dilation |
| Gastrointestinal cancer | Large balloon dilation under endoscopy |
| Senile | Prolonged operation time |
| Female | Inexperience of operating physician |
Previous classification of iatrogenic duodenal perforations during endoscopic retrograde cholangiopancreatography
| Type | Stapfer | Howard | Enns | Kim |
|---|---|---|---|---|
| I | Lateral or medial duodenal wall perforation, endoscope related | Guidewire perforation | Oesophageal, gastric, and duodenal perforation | Scope itself |
| II | Periampullary perforations, sphincterotomy related | Periampullary perforation | Periampullary perforation | Needle knife used during the sphincterotomy |
| III | Ductal or duodenal perforations due to endoscopic instruments | Duodenal perforation | Guidewire-related perforation | Guidewire and is associated with the least risk of contamination |
| IV | Guidewire-related perforation with presence of retroperitoneal air at X-ray | None | None | None |
New classification of iatrogenic duodenal perforations during endoscopic retrograde cholangiopancreatography
| Type | Miłek | Bray | Wu |
|---|---|---|---|
| I | Extraperitoneal (Duodenum except for duodenal bulb) Common bile duct Ampulla of Vater | Retroperitoneal contrast identified during ERCP | Air-alone groups |
| II | Intraperitoneal Duodenal bulb | Retroperitoneal air on subsequent imaging | Air-fluid groups |
| III | None | Retroperitoneal fluid on subsequent imaging | Fluid-alone groups |
| IV | None | Intraperitoneal air or fluid | None |
Figure 1The proportion of Stapfer classification
Figure 2Diagnosis or treatment time and mortality reported in some literature
Characteristics of perforation and corresponding endoscopic treatment methods
| Endoscopic modes | Endoclips or Endoloops or OTSC, | FC-SEMS | Fibrin glue | Purse-string suture | EBL | Covered metal stent | ENPT or vacuum therapy with OFD | Endoscopic scissor and Clips | Tulip bundle |
|---|---|---|---|---|---|---|---|---|---|
| Perforation type | Stapfer I (1–2 cm) | Stapfer II and III | Stapfer II and Secondary closure | Stapfer I (2 cm) and Titanium clips failed | Any perforation (1–2 cm and > 2 cm) | Balloon dilation | Stapfer II | Stent displacement | OTSC failed |
EBL – double endoscopic band ligation, ENPT – endoscopic negative pressure therapy, OFD – open-pore film drainage.
Figure 3Therapeutic diagram of endoscopic closing duodenal perforations. A – Endoscopic retrograde cholangiopancreatography (ERCP)-related duodenal perforations. B – Endoclips and Endoloops. C – Pursestring suture. D – Fully covered self-expandable metallic stent (FC-SEMS). E – Fibrin glue. F – Endoscopic band ligation (EBL). G – Over-the-scope clip (OTSC). H – Tulip bundle
Figure 4Algorithm of the management of endoscopic retrograde cholangiopancreatography (ERCP)-related duodenal perforations
PIS – peritonitis.